Aviva PLC lowered its stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) by 24.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 74,847 shares of the company's stock after selling 24,151 shares during the quarter. Aviva PLC owned about 0.06% of Revvity worth $8,354,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in RVTY. Victory Capital Management Inc. raised its holdings in Revvity by 17.4% during the fourth quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock worth $7,841,000 after purchasing an additional 10,390 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Revvity by 13.7% in the third quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock valued at $43,961,000 after buying an additional 41,497 shares in the last quarter. Contravisory Investment Management Inc. grew its holdings in Revvity by 1,715.9% during the fourth quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company's stock worth $7,722,000 after acquiring an additional 65,376 shares during the period. FMR LLC raised its position in Revvity by 40.8% in the third quarter. FMR LLC now owns 155,556 shares of the company's stock worth $19,872,000 after acquiring an additional 45,040 shares in the last quarter. Finally, Janney Montgomery Scott LLC lifted its holdings in Revvity by 87.0% in the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock valued at $881,000 after acquiring an additional 3,672 shares during the period. Institutional investors and hedge funds own 86.65% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the company. Raymond James restated an "outperform" rating and issued a $145.00 price target (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. KeyCorp raised their price target on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Sanford C. Bernstein lowered shares of Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective on the stock. in a research report on Friday, January 10th. Finally, Barclays dropped their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday. Four analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $133.75.
Check Out Our Latest Report on Revvity
Insider Activity
In related news, insider Joel S. Goldberg sold 15,170 shares of the firm's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares of the company's stock, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.68% of the company's stock.
Revvity Stock Performance
RVTY stock traded up $1.15 on Monday, reaching $96.01. The company's stock had a trading volume of 153,534 shares, compared to its average volume of 883,014. Revvity, Inc. has a 52 week low of $89.61 and a 52 week high of $129.50. The firm has a fifty day moving average of $109.12 and a two-hundred day moving average of $115.09. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The company has a market capitalization of $11.54 billion, a P/E ratio of 43.44, a price-to-earnings-growth ratio of 3.82 and a beta of 1.07.
Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period in the prior year, the firm posted $1.25 EPS. As a group, analysts predict that Revvity, Inc. will post 4.94 EPS for the current fiscal year.
Revvity Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.29%. The ex-dividend date is Thursday, April 17th. Revvity's dividend payout ratio (DPR) is currently 12.67%.
About Revvity
(
Free Report)
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Further Reading
Before you consider Revvity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.
While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
